DDX53 and neoplasm: Our results confirmed that the gut microbiome played a key role in the treatment of CT26 tumor-bearing mice with PD-1 inhibitors, especially the Prevotella_sp._CAG:485 and Akkermansia to PD-1 inhibitors have important significance in the treatment of CT26 tumor-bearing mice.